Message from CEO

  A large number of patients develop liver diseases over the world, but the patients who can receive donor livers are very little. For the liver disease treatment, the liver cell sheets, which made of mesenchymal stem cells (MSCs) in human living body, have been developed by Prof. Goshi Shiota of Tottori University. (Sci Rep. 2015, 5: 16169.)
  The liver cell sheet treatment can reduce both acute injuring and liver fibrosis caused by chronic injuring, by putting onto the liver surface. Liver fibrosis become worse to liver cirrhosis and carcinogenesis. So, we expect that liver cell sheets will be an effective treatment for these liver disease.
  I am challenging research and development in order to offer you this wonderful technology.

July 2017
Yohei KONO
President and CEO, KanonCure Inc.

About Us

Name KanonCure Inc.
Adress Tottori Univ. Alesco Bldg. 604,
86 Nishi-cho, Yonago, Tottori,
683-0826 Japan
Established April 25, 2016
Capitalization JPY 13,000,000 Yen
Unquoted share 40,000 shares
President & CEO Yohei KONO
Business Overview Research and development of regenerative medical products

<< Back